Related Experiment Video
Updated: Jan 21, 2026

Bioassays for Monitoring Insecticide Resistance
Published on: December 30, 2010
Best practices in bioassay development to support registration of biopharmaceuticals
John R White1, Marla Abodeely2, Sammina Ahmed3
1Biopharmaceutical Development GlaxoSmithKline R&D, 1250 S Collegeville Rd, Collegeville, PA 19426, USA.
Abstract:
Biological activity is a critical quality attribute for biopharmaceuticals, which is accurately measured using an appropriate relative potency bioassay. Developing a bioassay is a complex, rigorous undertaking that needs to address several challenges including modelling all of the mechanisms of action associated with the biotherapeutic. Bioassay development is also an exciting and fast evolving field, not only from a scientific, medical and technological point of view, but also in terms of statistical approaches and regulatory expectations. This has led to an industry-wide discussion on the most appropriate ways to develop, validate and control the bioassays throughout the drug lifecycle.
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
Self-Help Support Groups
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Support Reactions
The purpose of the supports is to prevent the translational motion of the system by applying an equal and opposite force and to prevent the system's rotation by applying...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Characteristics of Practical Op Amps
The ratio of differential gain to the common-mode gain is defined as the common-mode rejection ratio (CMRR). This ratio quantifies the ability of operational amplifiers (op-amps) to reject common-mode...

